CytoVac

Hørsholm, Denmark
VISIT WEBSITE
CytoVac A/S is a Danish clinical-stage biopharmaceutical company founded in 2008 that specializes in developing novel immunotherapies using autologous cell therapy technology. The company's lead program, ALECSAT (Autologous Lymphoid Effector Cells Specific against Tumor-cells), is a proprietary cancer immunotherapy that extracts a patient's blood sample and produces and activates Cytotoxic T cells (CTL) and Natural Killer (NK) cells ex-vivo. These activated immune cells are then reintroduced to attack cancer cells and activate the patient's immune system. CytoVac's focus is primarily on orphan oncology indications, with clinical development concentrated on glioblastoma multiforme (GBM), triple-negative breast cancer (TNBC), and previously pancreatic and prostate cancers. The company operates GMP-approved manufacturing facilities in Denmark with a current annual production capacity of approximately 200 doses.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Immuno-oncology, Cell Therapy
SIZE & FINANCIALS
Employees:1-50
Founded:2008
Ownership:private
Status:operating
FUNDING
Stage:Series Unknown/Mature Seed
Total Raised:$10.9M
Investors:Danish Tech Challenge, 250 Danish and Swedish private investors
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase II (GBM and TNBC)
Modalities:Autologous cell therapy, NK cell therapy, CTL therapy
Active Trials:2
Trial Phases:Phase 2: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Odense University Hospital (CV007 TNBC trial collaboration), Scandinavian hospital networks for clinical trial execution, CRO companies for clinical trial management
COMPETITION
Position:Niche Player
Competitors:Fate Therapeutics, Celularity Inc., Nektar Therapeutics (NKTR-214), Innate Pharma (Monalizumab), Artiva Biotherapeutics, Dragonfly Therapeutics, Amgen, Nkarta +3 more
LEADERSHIP
Key Executives:
Lone Dahl Andersen - CEO
Alexei Kirkin - Chief Scientific Officer
Walter Fischer - MD, PhD
Scientific Founders:Dr. Alexei Kirkin, Dr. Karine Dzhandzhougazyan, Bent Alsø
Board Members:Jan Kuhlmann Andersen (Board Member), Per Falholt (Board Member and Advisor)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with CytoVac. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.